MY112232A - Indole derivatives - Google Patents

Indole derivatives

Info

Publication number
MY112232A
MY112232A MYPI93000690A MYPI19930690A MY112232A MY 112232 A MY112232 A MY 112232A MY PI93000690 A MYPI93000690 A MY PI93000690A MY PI19930690 A MYPI19930690 A MY PI19930690A MY 112232 A MY112232 A MY 112232A
Authority
MY
Malaysia
Prior art keywords
group
amino
hydroxy
alkyl
indole derivatives
Prior art date
Application number
MYPI93000690A
Other languages
English (en)
Inventor
Gaviraghi Giovanni
Cugola Alfredo
Giacobbe Simone
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of MY112232A publication Critical patent/MY112232A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
MYPI93000690A 1992-04-16 1993-04-15 Indole derivatives MY112232A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929208492A GB9208492D0 (en) 1992-04-16 1992-04-16 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
MY112232A true MY112232A (en) 2001-05-31

Family

ID=10714220

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI93000690A MY112232A (en) 1992-04-16 1993-04-15 Indole derivatives

Country Status (41)

Country Link
US (4) US5374649A (member.php)
EP (1) EP0568136A1 (member.php)
JP (2) JPH07505407A (member.php)
KR (1) KR100264114B1 (member.php)
CN (1) CN1042331C (member.php)
AP (1) AP480A (member.php)
AT (1) AT403917B (member.php)
AU (1) AU666927B2 (member.php)
BE (1) BE1006343A5 (member.php)
BG (1) BG62136B1 (member.php)
BR (1) BR1100323A (member.php)
CA (3) CA2094073A1 (member.php)
CH (1) CH685630A5 (member.php)
CY (1) CY2038B1 (member.php)
CZ (1) CZ285799B6 (member.php)
DK (1) DK169890B1 (member.php)
ES (1) ES2105924B1 (member.php)
FI (1) FI106198B (member.php)
FR (1) FR2690919B1 (member.php)
GB (2) GB9208492D0 (member.php)
GE (1) GEP19991704B (member.php)
GR (1) GR1001619B (member.php)
HK (1) HK95797A (member.php)
HU (2) HU217964B (member.php)
IL (1) IL105412A (member.php)
IS (1) IS3994A (member.php)
IT (1) IT1265325B1 (member.php)
LU (1) LU88248A1 (member.php)
MX (1) MX9302195A (member.php)
MY (1) MY112232A (member.php)
NO (1) NO301879B1 (member.php)
NZ (1) NZ247413A (member.php)
OA (1) OA10103A (member.php)
PL (1) PL176451B1 (member.php)
RO (1) RO113242B1 (member.php)
RU (1) RU2129544C1 (member.php)
SE (1) SE504336C2 (member.php)
SK (1) SK281941B6 (member.php)
TW (1) TW224457B (member.php)
WO (1) WO1993021153A1 (member.php)
ZA (1) ZA932642B (member.php)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304500D0 (en) * 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
ATE151750T1 (de) * 1993-05-27 1997-05-15 Merrell Pharma Inc 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind
GB9319243D0 (en) * 1993-09-17 1993-11-03 Glaxo Spa Heterocyclic compounds
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
TW280819B (member.php) * 1993-11-17 1996-07-11 Sumitomo Pharma
US5563157B1 (en) 1994-10-31 1999-02-02 Hoecst Marion Roussel Inc Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
GB9504361D0 (en) * 1995-03-04 1995-04-26 Glaxo Spa Heterocyclic compounds
US6030968A (en) * 1996-09-17 2000-02-29 The Regents Of The University Of California Positive AMPA receptor modulation to enhance brain neurotrophic factor expression
NZ334343A (en) * 1996-09-30 2001-01-26 Hoechst Marion Roussel Inc NMDA (n-methyl-d-aspartate) antagonists which preferentially bind to the strychnine-insensitive glycine binding site on the NMDA receptor complex
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
US6440458B1 (en) * 1998-03-26 2002-08-27 Fujisawa Pharmaceutical Co., Ltd. Sustained release preparations
MXPA03000861A (es) * 2000-07-31 2004-04-05 Dainippon Pharmaceutical Co Remedios para la demencia que contienen derivados de 2-abril-8-oxodihidropurina como ingrediente activo.
WO2003039540A2 (en) * 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
CA2468544A1 (en) * 2001-12-10 2003-06-19 Amgen Inc. Vanilloid receptor ligands
PA8579701A1 (es) * 2002-08-23 2005-05-24 Pfizer Prod Inc Profarmaco inhibidor de beta-lactamasa
DE10306202A1 (de) * 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
EP1636240A1 (en) * 2003-06-05 2006-03-22 Pfizer Products Inc. Beta-lactamase inhibitor prodrug
RU2247563C1 (ru) * 2003-06-16 2005-03-10 Пятигорская государственная фармацевтическая академия Способ получения твердой лекарственной формы, содержащей глюкозамина гидрохлорид
DK1689721T3 (da) * 2003-11-26 2010-09-20 Pfizer Prod Inc Aminopyrazolderivater som GSK-3-ihibitorer
KR20060128976A (ko) * 2003-12-29 2006-12-14 세프라코 아이엔시. 피롤 및 피라졸 디에이에이오 억제제
RU2281755C2 (ru) * 2004-04-19 2006-08-20 Пятигорская государственная фармацевтическая академия Композиция - лекарственная форма противоартрозного средства глюкозамина гидрохлорида для ректального применения
US20060002999A1 (en) * 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
CA2957667A1 (en) 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
WO2007081857A2 (en) * 2006-01-06 2007-07-19 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
KR101381768B1 (ko) 2006-01-06 2014-04-07 선오비온 파마슈티컬스 인코포레이티드 테트랄론-기재 모노아민 재흡수 저해제
AU2007233041B2 (en) 2006-03-31 2013-05-02 Sepracor Inc. Preparation of chiral amides and amines
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US20080082066A1 (en) * 2006-10-02 2008-04-03 Weyerhaeuser Co. Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
EP1942104A1 (en) 2006-12-20 2008-07-09 sanofi-aventis Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
EP2074092A2 (en) 2007-01-18 2009-07-01 Sepracor Inc. Inhibitors of d-amino acid oxidase
US7902252B2 (en) * 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
CA2688493C (en) 2007-05-31 2016-04-19 Sepracor Inc. Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
US20090247644A1 (en) * 2008-03-28 2009-10-01 Forest Laboratories Holdings Limited Memantine formulations
US20100120740A1 (en) * 2008-08-07 2010-05-13 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
KR20110126132A (ko) * 2009-03-10 2011-11-22 산텐 세이야꾸 가부시키가이샤 4,6-디클로로-1η-인돌-2-카르복실산 유도체 또는 이의 염을 유효 성분으로서 함유하는 시신경 장애의 예방 또는 치료제
US20110034434A1 (en) * 2009-08-07 2011-02-10 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
DK3137658T3 (da) 2014-04-30 2022-05-02 Yufeng Jane Tseng Anvendelse af kendte forbindelser som d-aminosyreoxidase-inhibitorer
KR20240042153A (ko) 2016-09-14 2024-04-01 위펑 제인 쳉 D-아미노산 옥시다제 (daao) 저해제로서 신규한 치환된 벤즈이미다졸 유도체
BR112019026449A2 (pt) 2017-06-12 2020-08-11 Glytech Llc. composição e método para tratamento de depressão e psicose em humanos
CN112707874A (zh) * 2020-12-29 2021-04-27 广东中科药物研究有限公司 一种抗病毒化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3010971A (en) * 1960-08-04 1961-11-28 Smith Kline French Lab Cyclopropylamine derivatives and processes for their preparation
DK500285A (da) * 1984-11-02 1986-05-03 Glaxo Group Ltd Cephalosporinantibiotika
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
PT93943A (pt) * 1989-05-05 1991-02-08 Searle & Co Processo para a preparacao de composicoes contendo compostos indole-2-carboxilato para tratamento de perturbacoes do snc
HU216787B (hu) * 1990-07-16 1999-08-30 Merrell Dow Pharmaceuticals Inc. Eljárás excitátoros aminosav-antagonista hatású indolszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
US5145845A (en) * 1991-05-14 1992-09-08 Warner-Lambert Co. Substituted 2-carboxylindoles having pharmaceutical activity

Also Published As

Publication number Publication date
CA2094073A1 (en) 1993-10-17
HK95797A (en) 1997-08-08
FI944800L (fi) 1994-10-12
CA2094076A1 (en) 1993-10-17
CH685630A5 (fr) 1995-08-31
KR100264114B1 (ko) 2000-11-01
PL176451B1 (pl) 1999-05-31
FI944800A0 (fi) 1994-10-12
RO113242B1 (ro) 1998-05-29
HU211826A9 (en) 1995-12-28
RU2129544C1 (ru) 1999-04-27
ITRM930236A0 (it) 1993-04-15
IS3994A (is) 1993-10-17
FR2690919B1 (fr) 1995-05-05
MX9302195A (es) 1994-03-31
SK124194A3 (en) 1995-05-10
NO301879B1 (no) 1997-12-22
BG62136B1 (bg) 1999-03-31
TW224457B (member.php) 1994-06-01
DK43193A (da) 1993-10-17
US5374648A (en) 1994-12-20
GR1001619B (el) 1994-07-29
US5373018A (en) 1994-12-13
CN1042331C (zh) 1999-03-03
CA2094075A1 (en) 1993-10-17
IL105412A (en) 1998-02-22
IL105412A0 (en) 1993-08-18
ZA932642B (en) 1994-01-10
CY2038B1 (en) 1998-04-30
SE504336C2 (sv) 1997-01-13
IT1265325B1 (it) 1996-10-31
GEP19991704B (en) 1999-08-05
SE9301241L (sv) 1993-10-17
AT403917B (de) 1998-06-25
JPH0649027A (ja) 1994-02-22
GB2266091A (en) 1993-10-20
OA10103A (en) 1996-12-18
HUT70526A (en) 1995-10-30
NO943913L (no) 1994-12-14
LU88248A1 (fr) 1994-03-01
FR2690919A1 (fr) 1993-11-12
ATA75293A (de) 1997-11-15
GB2266091B (en) 1995-08-09
DK43193D0 (da) 1993-04-15
SE9301241D0 (sv) 1993-04-15
WO1993021153A1 (en) 1993-10-28
CN1085212A (zh) 1994-04-13
ES2105924A1 (es) 1997-10-16
AU666927B2 (en) 1996-02-29
AP480A (en) 1996-03-22
CZ254394A3 (en) 1995-07-12
CZ285799B6 (cs) 1999-11-17
BE1006343A5 (fr) 1994-07-26
DK169890B1 (da) 1995-03-27
ITRM930236A1 (it) 1994-10-15
AP9300524A0 (en) 1993-04-30
GB9208492D0 (en) 1992-06-03
JPH07505407A (ja) 1995-06-15
FI106198B (fi) 2000-12-15
RU94045915A (ru) 1996-09-10
HU217964B (hu) 2000-05-28
EP0568136A1 (en) 1993-11-03
AU3692393A (en) 1993-10-21
SK281941B6 (sk) 2001-09-11
BG99111A (bg) 1995-05-31
NO943913D0 (no) 1994-10-14
GB9307808D0 (en) 1993-06-02
US5374649A (en) 1994-12-20
ES2105924B1 (es) 1998-07-01
NZ247413A (en) 1995-12-21
HU9402975D0 (en) 1995-02-28
US5510367A (en) 1996-04-23
BR1100323A (pt) 2000-06-27

Similar Documents

Publication Publication Date Title
MY112232A (en) Indole derivatives
DE3854454D1 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung.
DK0528337T3 (da) Thiazolylbenzofuranderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater, der indeholder disse forbin
TW369533B (en) Quinoline compounds, process for preparing them and pharmaceutical composition containing them
ATE164575T1 (de) Substituierte aromatische verbindungen als c. amp phosphodiesterase-und tnf-hemmer
TR199800924T2 (xx) Quinoline t�revleri.
IL95675A0 (en) Pyrazole derivatives,processes for preparation thereof and pharmaceutical compositions containing the same
HUP0100615A2 (hu) Szubsztituált 2-(2,6-dioxo-3-fluoro-piperidin-3-il)-izoindolinok és ezek alkalmazása TNFalfa-szint csökkentésére
MY113208A (en) Pharmaceutical and compositions inhibiting kinases
IL101785A0 (en) Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
EP0787726A4 (member.php)
NZ333812A (en) Tetrahydroquinoline derivatives as excitatory amino acid (EAA) antagonists useful for neurodegenerative diseases
CA2214759A1 (en) Intimal hypertrophy inhibitors
PL330994A1 (en) Indolic derivatives for use in treating osteoporosis
DE69511260D1 (en) Bicyclische amidinderivate als no-synthetase inhibitoren
CA2244777A1 (en) 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
EA200100090A3 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
EP0315434A3 (en) Pyridoxal hydrazone derivatives their production and use and pharmaceutical compositions containing the same
IL148590A0 (en) Alkaloid compounds and pharmaceutical compositions containing the same
IL99065A0 (en) N,n'n'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-diones
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
HU9202849D0 (en) Method for producing n,n',n-trisubstituted- 5-bis-amino-methylene-1,3-dioxane-4,6-dione derivatives and pharmaceutical preparatives containing them
EP0160969A3 (en) Cephem compounds
FR2823749B1 (fr) Phenyl- et pyridyl-piperidines, procede pour leur preparation et compositions pharmaceutiques les contenant